Skip to main content

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chen's full profile

Already have an account?

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Nephrology, 2006 - 2008
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2005
  • Beijing Medical University
    Beijing Medical UniversityClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Loss of Function of NF1 Is a Mechanism of Acquired Resistance to Endocrine Therapy in Lobular Breast Cancer  
    A V Lee, Y X Feng, J Chung, S Ali, J Chen, J S Ross, Annals of Oncology
  • Tissue Plasminogen Activator Promotes White Matter Integrity and Functional Recovery in a Murine Model of Traumatic Brain Injury  
    Jun Chen, MD, Proceedings of the National Academy of Sciences

Press Mentions

  • Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV InfectionSeptember 15th, 2022
  • Fast-Acting Immune Cells Provide Powerful Protection Against Stroke
    Fast-Acting Immune Cells Provide Powerful Protection Against StrokeAugust 1st, 2022
  • Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV InfectionJuly 3rd, 2022
  • Join now to see all

Hospital Affiliations